| 4534 |
Undertaking a needs assessment |
21/03/2023 |
|
| 4536 |
Using the Bundling Approach |
21/03/2023 |
|
| 4538 |
Stakeholder mapping for partnerships |
21/03/2023 |
|
| 272 |
Gender Aspects of TB |
21/03/2023 |
|
| 4540 |
National Framework for A Gender-Responsive Approach to TB in India |
21/03/2023 |
|
| 241 |
TB Treatment Initiation |
27/03/2023 |
|
| 79 |
Nikshay |
31/03/2023 |
|
| 3541 |
Generation of benefits by Nikshay for PPs and informants |
31/03/2023 |
|
| 3539 |
Steps for processing payments for Treatment Supporters |
31/03/2023 |
|
| 3729 |
Public Finance Management System |
31/03/2023 |
|
| 1641 |
Program Monitoring Indicators |
03/04/2023 |
|
| 4567 |
Monitoring indicators related to Notification |
03/04/2023 |
|
| 4568 |
Monitoring indicators related to UDST |
03/04/2023 |
|
| 4572 |
Role of CHO in TB Prevention |
04/04/2023 |
|
| 4573 |
Role of CHO in NTEP |
04/04/2023 |
|
| 4576 |
Role of AB-HWCs in NTEP |
04/04/2023 |
|
| 113 |
India's commitment to End TB |
05/04/2023 |
|
| 734 |
Strategies for TB Treatment |
05/04/2023 |
|
| 4579 |
Shorter Injectable-containing MDR/RR-TB Regimen: Eligibility Criteria |
05/04/2023 |
|
| 4580 |
Shorter Injectable-containing MDR/RR-TB Regimen: Regimen and Duration |
05/04/2023 |
|
| 4623 |
Role of SHC-HWC in TB Case Management and Support |
06/04/2023 |
|
| 4645 |
Role of a DTO |
10/04/2023 |
|
| 2613 |
Patient-wise Boxes [PWB] |
10/04/2023 |
|
| 4649 |
General Terms related to PIP |
11/04/2023 |
|
| 4650 |
PIP cycle |
11/04/2023 |
|
| 4651 |
FMR code |
11/04/2023 |
|
| 4653 |
Flow of funds from NHM to NTEP |
11/04/2023 |
|
| 4654 |
Supplementary PIP |
11/04/2023 |
|
| 4655 |
Identification of Gaps using the Known Program Indicators- Case Finding |
11/04/2023 |
|
| 4656 |
Identification of Gaps using the Known Program Indicators- TB Treatment |
11/04/2023 |
|
